<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000816.v2.p1" parentStudy="phs000816.v2.p1" createDate="2016-04-19" modDate="2016-04-19">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>David W. Craig PhD</td><td>Neurogenomics Division, Center for Rare Childhood Disorders, The Translational Genomics Research Institute, Phoenix, AZ, USA</td></tr>
		<tr><td>Funding Sources</td><td>Stardust Foundation</td><td>Stardust Foundation, Paradise Valley, AZ, USA</td></tr>
		<tr><td>Funding Sources</td><td>TGEN Foundation</td><td>Translational Genomics Research Institute (TGEN), Phoenix, AZ, USA</td></tr>
		<tr><td>Funding Sources</td><td>State of Arizona</td><td>The State of Arizona, Phoenix, AZ, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Characterization of X Chromosome Inactivation by high-throughput sequencing</StudyNameEntrez>
	<StudyNameReportPage>Characterization of X Chromosome Inactivation Using Integrated Analysis of Whole-Exome and mRNA Sequencing</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Parent-Offspring Trios</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This study of DNA and RNA sequencing of 5 parent-offspring trios is a single center study. The goal of this study is to characterize X chromosome inactivation (XCI) ratio in females using phased genomic variations obtained through whole genome or exome sequencing in trios, followed by allele-specific expression analysis of the phased, heterozygous alleles in the mRNA of the female offspring, and to apply this method to clinical diagnosis. The distribution of allele ratios across X obtained from mRNA sequencing allows for the estimation of X inactivation status of inherited X chromosomes, and the parameters of each parental allele distributions in the offspring&#39;s mRNA data can be used as determinants for XCI ratio. This approach was used to evaluate the contribution of skewed XCI ratio to phenotypic heterogeneity in an undiagnosed, mild neurological condition.</p>]]>
	</Description>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="25503791"/>
		</Publication>
		<Publication>
			<Pubmed pmid="26091538"/>
		</Publication>
		<Publication>
			<Journal authors="Moskowitz AM, Belnap N, Siniard AL, Szelinger S, Claasen AM, Richholt RF, De Both M,Corneveaux JJ, Balak C, Piras IS, Russell M, Courtright AL, Rangasamy S, Ramsey KR, Craig DW, Narayanan V, Huentelman MJ, Schrauwen I" title="A de novo missense mutation in ZMYND11 is associated with global developmental delay, seizures and hypotonia" journal="Cold Spring Harbor Molecular Case Studies, Pending Acceptance"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="X Chromosome Inactivation"/>
		<Disease vocab_source="MESH" vocab_term="Genes, X-Linked"/>
		<Disease vocab_source="MESH" vocab_term="Neurobehavioral Manifestations"/>
		<Disease vocab_source="MESH" vocab_term="Chromosome Deletion"/>
		<Disease vocab_source="MESH" vocab_term="Aicardi Syndrome"/>
		<Disease vocab_source="MESH" vocab_term="Intellectual disability"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>David W. Craig PhD</AttName>
			<Institution>Neurogenomics Division, Center for Rare Childhood Disorders, The Translational Genomics Research Institute, Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>Stardust Foundation</AttName>
			<Institution>Stardust Foundation, Paradise Valley, AZ, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>TGEN Foundation</AttName>
			<Institution>Translational Genomics Research Institute (TGEN), Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Funding Sources">
			<AttName>State of Arizona</AttName>
			<Institution>The State of Arizona, Phoenix, AZ, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHGRI</DacName>
      <DacFullName>National Human Genome Research Institute</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000816.v2.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000816.v2.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000816.v2.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
